A recent study showed that low expression of SATB2 was correlated with poor prognosis, tumor invasion, metastasis and Dukes' classification in colorectal cancer [21], further confirming the decreased level of SATB2 is a powerful prognostic factor in cancer. Here, SATB2 is linked to cancer.